跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Balversa
Approved
STANDARD
Balversa
Janssen Cilag S.p.A
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b6b4a0f0ac474618
Company
Janssen Cilag S.p.A
Type
Standard
Approval Details
Approval Id
b6b4a0f0ac474618
Drug Approval Philippines Name
Balversa
Product Name
Balversa
Registration Number
DR-XY48338
Brand Name
Balversa
Generic Name
Erdafitinib
Dosage Form
Film-Coated Tablet
Dosage Strength
3 mg
Manufacturer
Janssen Cilag S.p.A
Importer
Johnson & Johnson (Philippines), Inc.
Distributor
Johnson & Johnson (Philippines), Inc.
Issuance Date
28 September 2023
Expiry Date
02 September 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b6b4a0f0ac474618
Type
Standard
Back to Philippines FDA Approvals
Balversa - Philippines FDA Drug Approval Details